Takaisin

Cognitive behavioral therapy for fibromyalgia

Näytönastekatsaukset
Aleksi Varinen and Aleksi Raudasoja
3.3.2026

Level of evidence: C

Adding cognitive behavioral therapy to other standard care may slightly improve fibromyalgia-related symptoms compared to standard care only or active control.

A Cochrane review measured the impact of cognitive behavioral therapy (CBT) on fibromyalgia symptoms «Bernardy K, Klose P, Busch AJ, et al. Cognitive be...»1. It suggested a decrease in fibromyalgia-related pain of 8.5 % (95 % CI 3.1 % to 14.0 %) at the end of treatment. Furthermore, it suggested a reduction in negative mood (relative 15 %, 95 % CI 7.7 % to 22.3 %) and improvement in physical disability (relative 25 %, 95 % CI 6.9 % to 43.7 %). The impact may be slightly smaller in a longer follow-up (6 months). About half of the included studies included active control, such as education on pain management strategies and/or exercise.

Furthermore, CBT may slightly decrease fatigue (SMD -0.25 [-0.49 to -0.02]), sleep problems (SMD -0.40 [-0.85 to 0.05]), and improve health-related quality of life (SMD -0.23[-0.38 to -0.08]).

A couple of newer systematic reviews measured the impact of CBT on fibromyalgia symptoms and suggested a similar impact «Climent-Sanz C, Valenzuela-Pascual F, Martínez-Nav...»2, «Pathak A, Kelleher EM, Brennan I, et al. Treatment...»3.

Adverse events were not reported.

The quality of evidence was downgraded due to imprecision, study limitations, and indirectness.

Table 1. Description of the included studies
Reference Study type Population Intervention and comparison Outcomes Risk of bias
«Bernardy K, Klose P, Busch AJ, et al. Cognitive be...»1 SR/MA Adult patients with Fibromyalgia Cognitive behavioral therapy vs placebo Pain, mood, disability, sleep problems High
RCT=randomized controlled trial; SR=systematic review; MA=meta-analysis
Table 2. Additional comments for included studies.
Reference Comments
«Bernardy K, Klose P, Busch AJ, et al. Cognitive be...»1 Both groups could include co-interventions such as medication. About half of the trials included active control, such as education on pain management or exercise.
RoB:
Randomization: OK,
Allocation concealment: insufficiently reported in most trials,
Missing data: most trials either did not report, had per-protocol analysis, or had large amount of missing data
Blinding: no blinding

Results

Table 3. Outcome 1. Pain (VAS or NRS) [0-10] at the end of treatment
Reference Number of studies and number of patients (I/C) Follow-up time Mean (SD) I Mean (SD) C Mean difference (95% CI)
«Bernardy K, Klose P, Busch AJ, et al. Cognitive be...»1 20 trials, 1382 patients 2-12 months Not reported Not reported SMD -0.29 (-0.47 to -0.11)
Relative effect:
-8.5 % (-3.1 % to -14.0 %)
Level of evidence: Low
The quality of evidence was downgraded one time due to imprecision, and one time due to study limitations.
We did not rate down more because of indirectness since some trials having active control likely bias the impact towards null.
I=intervention; C=comparison; CI=confidence interval
Table 4. Outcome 2. Negative mood [0-10] at the end of treatment
Reference Number of studies and number of patients (I/C) Follow-up time Mean (SD) I Mean (SD) C Mean difference (95% CI)
«Bernardy K, Klose P, Busch AJ, et al. Cognitive be...»1 18 trials, 1578 patients 2-12 months Not reported Not reported SMD -0.33 (-0.49 to -0.17)
Relative effect:
-15.0 % (-7.7 % to -22.3 %)
Level of evidence: Low
The quality of evidence was downgraded one time due to imprecision, and one time due to study limitations.
We did not rate down more because of indirectness since some trials having active control likely bias the impact towards null.
I=intervention; C=comparison; CI=confidence interval
Table 5. Outcome 3. Disability [0-10] at the end of treatment
Reference Number of studies and number of patients (I/C) Follow-up time Mean (SD) I Mean (SD) C Mean difference (95% CI)
«Bernardy K, Klose P, Busch AJ, et al. Cognitive be...»1 15 trials, 1163 patients 2-12 months Not reported Not reported SMD -0.30 (-0.51 to -0.08)
Relative effect:
25.8 % (6.9 % to 43.7 %) improvement
Level of evidence: Low
The quality of evidence was downgraded one time due to imprecision, and one time due to study limitations.
We did not rate down more because of indirectness since some trials having active control likely bias the impact towards null.
I=intervention; C=comparison; CI=confidence interval

References

  1. Bernardy K, Klose P, Busch AJ, et al. Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev 2013;2013(9):CD009796 «PMID: 24018611»PubMed
  2. Climent-Sanz C, Valenzuela-Pascual F, Martínez-Navarro O, et al. Cognitive behavioral therapy for insomnia (CBT-i) in patients with fibromyalgia: a systematic review and meta-analysis. Disabil Rehabil 2022;44(20):5770-5783 «PMID: 34297651»PubMed
  3. Pathak A, Kelleher EM, Brennan I, et al. Treatments for enhancing sleep quality in fibromyalgia: a systematic review and meta-analysis. Rheumatology (Oxford) 2025;64(8):4495-4516 «PMID: 40084994»PubMed